Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06548399 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Longitudinal Study on Bacterial Production of LPC and LPA in Patients With Inflammatory Bowel Disease

Study acronym: Long-IBD
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years 4 months later Oct 31, 2024 → Mar 30, 2027
See other at-risk trials from McMaster University

Record History

  1. Primary completion pushed from Oct 31, 2024 to Mar 30, 2027 Start date pushed from Dec 1, 2023 to Dec 1, 2024 · Primary endpoints: details revised at 1 of 1 entry · Trial status changed: Unknown → Recruiting · 5 more Show 8 more changesShow less
    • Start date pushed from Dec 1, 2023 to Dec 1, 2024
    • Primary endpoints: details revised at 1 of 1 entry
    • Trial status changed: Unknown → Recruiting
    • Completion pushed from Dec 1, 2024 to May 30, 2027
    • Eligibility criteria expanded, about 8 words
    • Secondary endpoints: details revised at 2 of 2 entries
    • Study description shortened, about 6 words
    • Site contact updated
  2. Changed Registry marked status Unknown; last known: Recruiting
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to investigate whether the gut bacteria in IBD patients cause ongoing abdominal pain, even when the disease is calm. Many inflammatory bowel disease (IBD) patients have this pain, regardless of whether their disease is active or not. This might be linked to an imbalance in gut bacteria. Certain IBD patients with persistent abdominal pain experience increased sensitivity in their gut due to bacteria producing LPC and LPA. Our goal is to explore the connection between bacterial LPC/LPA levels and symptoms in IBD patients with long-lasting abdominal pain. Additionally, we aim to pinpoint the specific bacteria responsible for producing LPC/LPA, which in turn causes chronic abdominal pain in these patients.
Trial Details
NCT Number NCT06548399
Lead Sponsor McMaster University
Conditions Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov